Abstract The criminal justice (CJ) system can be leveraged to access women for HIV prevention and treatment programs. Research is lacking on effective implementation strategies tailored to the specific needs of CJ-involved women. We conducted a scoping review of published studies in English from the United States that described HIV interventions, involved women or girls, and used the CJ system as an access point for sampling or intervention delivery. We identified 350 studies and synthesized data from 42 unique interventions, based in closed (n = 26), community (n = 7), or multiple/other CJ settings (n = 9). A minority of reviewed programs incorporated womenspecific content or conducted gender-stratified analyses. CJ systems are comprised of diverse access points, each with unique strengths and challenges for implementing HIV treatment and prevention programs for women. Further study is warranted to develop women-specific and traumainformed content and evaluate program effectiveness.
Introduction
Women in the criminal justice (CJ) system in the United States have been disproportionately impacted by the HIV epidemic [1] [2] [3] [4] . The U.S. incarcerates more of its citizens, and more women, than any other country worldwide [5] . One in six people living with HIV (PLH) in the U.S. pass through prisons and jails annually [3] , and far more remain under community supervision. Women's experiences of both HIV and incarceration differ in important ways from men's. As opposed to men's individualistic drug use patterns, women often have overlapping sex and drug partners that increase exposure to HIV and other sexually transmitted infections (STIs) [6] . Within personal networks, relationships are frequently complicated by intimate partner violence (IPV) that reduces women's autonomy to modify drug use behaviors or engage in health promoting activities [7] [8] [9] . Incarcerated women also experience a higher burden of medical, psychiatric, and substance use disorders (SUDs) than incarcerated men [10] . These biological, behavioral, and social factors converge on structural gender-related health disparities, resulting in an HIV prevalence among incarcerated women that is twice that of incarcerated men [11, 12] .
Despite experiencing a disproportionate burden of disease, women are less likely than men to have access to HIV prevention or treatment services or access to drug treatment during incarceration [13] . CJ-involved women are frequently Black or Latina, experience SUDs including injection drug use (IDU), commercial sex work (CSW), stigma, intimate partner violence (IPV), and confinement in closed settings, making them a key target population for HIV prevention [14, 15] . Yet just one of the 33 CDC evidence-based behavioral HIV prevention interventions listed on the ''diffusion'' website is specific to CJ populations [16] , and this program is limited to sexual risk reduction strategies for men only [17] . A condom-focused message, however, is unlikely to effectively curb the HIV epidemic in CJ-involved women whose HIV risk is related mostly to drug injection and other substance use, or who have less autonomy to negotiate condoms.
CJ systems can be potential points of access to women living with HIV. Incarceration can be an opportunity to diagnose HIV and effectively provide antiretroviral therapy (ART) to PLH who might not otherwise access regular sources of healthcare [2, 4, [18] [19] [20] [21] [22] . In a previous large retrospective cohort of PLH incarcerated in Connecticut, women were significantly more likely than their male counterparts to achieve viral suppression during incarceration [23] , though these optimal treatment outcomes are not sustained following transition to communities [24] .
CJ systems in the U.S. vary widely in terms of their organization, but essentially are comprised of closed facilities (prisons, jails, detention centers) and communitybased supervision sites (courts, probation, parole, transitional housing) [25] . Although CJ systems aim to protect the public, punish (and perhaps rehabilitate) offenders for public safety, they also represent opportunities to deliver healthcare and behavioral interventions to populations experiencing health disparities [26] . Given the intersecting epidemics of HIV and incarceration and to inform the development of women-specific HIV prevention and treatment interventions, we focus this scoping review on the U.S. CJ system as an access point to women for HIV interventions.
In doing so, we acknowledge and build on the previous work of others. Lichtenstein et al. first systematically reviewed HIV interventions for women prisoners [27] . This potentially limited relevance to women incarcerated in closed settings, who comprise just 10% of those who are CJ-involved. Underhill et al. reviewed HIV risk reduction interventions for adults (both men and women) in correctional and community settings [28] . This comprehensive review included heterogeneous study populations, ranging from people who use drugs to those with any lifetime history of CJ-involvement (including lifetime history of arrest) and did not address gender-specificity. Azhar et al. reviewed HIV prevention interventions, applying a very broad definition of CJ-involvement [29] .
These prior reviews contribute vitally to our understanding of the core components of HIV interventions for women in CJ system, but lack factors integral to intervention development and implementation science: (1) how to make HIV interventions or their evaluations womenspecific (and thus meaningful to the target audience); and (2) how to identify potential intervention recipients by using the CJ system as a focal point of contact for a population who may otherwise be challenging to engage in community settings. We designed the current study to focus on the gender-specificity of interventions and to span the full breadth of the CJ system (i.e., closed, community, and other settings)-issues that have not been adequately addressed previously.
Methods
We undertook a scoping review [30] of the published literature to address the questions: How can CJ systems be leveraged to reach women for evidence-based HIV interventions? How can HIV interventions be adapted to address the specific needs of women who are CJ-involved? Whereas a systematic review pre-defines a specific narrow research question and rates the quality of the evidence (e.g., What is the effect of HIV risk reduction behavioral interventions on condom use among women prisoners?), a scoping review more broadly probes existing literature about a concept or general topic (e.g., using the CJ system to deliver HIV interventions to women) [30] . In other words, a systematic review asks ''What?'' and a scoping review asks ''How?'' We searched PubMed, Ovid MED-LINE, PsycInfo, Embase, and Google Scholar using the following sets of MeSH terms: (1) HIV or AIDS; (2) women or gender or female; (3) criminal justice or prison or jail or probation or parole or police or court or incarcerat* or offend* or offens* or lock-up or lock up or transitional housing or court or criminal* or crime*. After combining the three term sets, we filtered based on full text or abstract available and clinical trial or review, added relevant citations from systematic reviews, and removed duplicates. Two authors (JM and DM) independently reviewed each abstract to apply the following inclusion criteria: (1) published manuscript or report available in English; (2) included any women; (3) specifically recruited CJ-involved populations or used the CJ system for recruitment or enrollment in the U.S.; (4) described a specific behavioral, social, or biomedical HIV intervention; and (5) measured the effect of the intervention on HIV treatment outcomes or HIV-related risk behaviors. We used the term HIV intervention to encompass both studies that intervened to prevent HIV (e.g., reduce risk behaviors, increase HIV testing) and studies that intervened to improve HIV treatment (e.g., linkage to or retention in care, antiretroviral adherence). We limited our search to U.S. based settings because the CJ system is nation-and state-specific, and we could not sufficiently address global issues by only searching databases in English. We did not exclude based on study methodology (e.g., randomized controlled trial, quasi-experimental, etc.). Studies published any time prior to the extraction date of October 1, 2016 were eligible for inclusion. After discussing and resolving discrepancies in each author's review (erring on the side of inclusion), 53 unique studies were included in the synthesis phase, as shown in Fig. 1 , in which we extracted relevant data into Tables according to the PRISMA checklist [31] . In addition, we evaluated whether the intervention was ''women-specific'', meaning the study only enrolled women, the intervention incorporated gender-responsive or trauma-informed content (i.e., acknowledging specific barriers to accessing or retaining women in care) or if gender was analyzed as a potential mediating or moderating variable. We also extracted data on implementation strengths and challenges to working within CJ systems, as identified by the study authors in the ''Results'' or ''Discussion'' sections. When multiple manuscripts described the same named intervention, only that describing primary outcomes and intervention efficacy was included in the table, with other associated studies (e.g., those describing adaptation processes, pilot data, or secondary outcomes) referenced within the row. Results were grouped by CJ access point, wherein we briefly described the scope of interventions then focused in on case examples of interventions that were women-specific.
Results
Closed CJ Settings or generally under local or state jurisdiction [32] . HIV interventions involved psychoeducational risk reduction, intensive case management for discharge planning, HIV testing [33] , adherence support (as directly administered antiretroviral therapy [34, 35] ) and medication-assisted treatment for substance use disorders (including extendedrelease naltrexone [82] , methadone [36] , and buprenorphine [37] ). The majority of interventions were related to HIV prevention and testing for selected ''high risk'' women offenders, although risk (as either an inclusion criteria or a measured outcome) was variously defined. All HIV prevention interventions were psychoeducational or behavioral; none were biomedical. Though most studies enrolled few female participants or were underpowered for a gender-stratified analysis, 12 enrolled only women or girls. Among these, 4 HIV interventions explicitly included women-specific and/or traumainformed content [38] [39] [40] [41] . Project POWER (Providing Opportunities for Women's Empowerment, Risk-Reduction, and Relationships), for example, was extensively adapted from a CDC evidence-based intervention (EBI) to include HIV disease knowledge, personal risk recognition, evaluation of behavioral change, self-efficacy, and attainment of skills in nine facilitator-led sessions prior to release [39] . Attrition was high post-release but there was still a significant intervention effect on self-reported condom use, knowledge, health-protective communication, and social support compared to a single HIV prevention session as usual. Similarly, Project RRR-HIV (Reducing Risky Relationships for HIV intervention) was a six-session interventionist-led group that targeted ''risky relationship myths'' [38] . A majority of the intervention group completed all five sessions, resulting in significantly decreased reported condomless sex in the intervention group at 90-days post-release compared to an HIV awareness video as usual group. Despite limitations noted in Table 1 (including a lack of measured biological outcomes like STI incidence), these gender-specific studies suggest the success of interventions that emphasize peer support, self-efficacy and awareness, and trauma-informed content for women and girls during incarceration.
From an implementation perspective, closed CJ settings overall provide highly structured and controlled settings, in which research staff are often able to maintain prolonged continuity of contact with participants and create buy-in from prison staff, even integrating program introductions into standard facility orientations (Table 4) . Onsite health and addiction treatment programs also provide a convenient point of contact to individuals with specific health conditions (e.g., HIV, opioid use disorders). These same settings, however, presented challenges to intervention implementation because of highly restricted access, and vulnerability to variability in local/state funding, policy/ law, correctional population control (e.g., individuals being moved to or released from facilities), and disease epidemiology. Whereas prisons seem to be optimal settings for multi-session or time-intensive interventions, the rapid turnover in jails and some juvenile detention centers requires time-limited programs or programs focused on transitional care or case management. Table 2 summarizes the seven interventions that used community CJ settings to deliver HIV interventions. Community settings broadly encompass all those that supervise individuals outside of closed facilities. Community settings include probation, in which individuals are under pre-trial supervision or completing a ''jail diversion'' or ''alternative to incarceration'' program; parole, in which individuals are supervised regularly following prison-release; mandated supervised community-based drug treatment programs, or transitional housing programs (that are community-based but affiliated with CJ systems of supervision [32] ). Interventions involved psycho-educational sessions, integrated care for substance use disorders, and transitional case management programs. All communitybased programs related to HIV testing or prevention; there were no studies that described interventions for women living with HIV to promote engagement in care along the HIV care continuum.
Community Supervision CJ Settings
Studies generally enrolled few women. A notable exception was Project WORTH (Women on the Road to Health) that enrolled 306 women from community courts and probation sites throughout New York City for an HIV and intimate partner violence (IPV) prevention program focused on risk reduction, negotiation, and empowerment skills [42] . Participants in intervention arms received either a facilitator-led program or a multimedia program with similar content. Both intervention arms had increased proportion of protected sex acts at 12-month follow-up compared to controls. Theoretically, the multimedia program has increased sustainability and scalability because it could be delivered in any setting by untrained staff, including probation offices. WORTH is recognized by the CDC as an EBI. These strengths reflect the overall potential for integrating interventions into community correction settings, after addressing the potential pitfalls of a heterogeneous population with high attrition, privacy concerns, and reluctance of staff to make participation seem mandatory (Table 4) .
Other or Multiple CJ Settings
In Table 3 , we summarize findings from the remaining nine studies that used other or multiple CJ access points and could not be categorized elsewhere. Sites included a prison visitor center [43] , a work-release program [44] , courts and booking sites targeting arrestees on pre-trial release [45] , alternative education programs for juveniles [46, 47] , a women's reentry center [48] , and juvenile drug court targeting adolescents post-plea [49] . Two studies partnered with community based organizations (CBOs) that worked with CJ-involved populations at a variety of sites [45, 48] . Although the variety of sites enabled program flexibility, it often resulted in heterogeneous study populations with low effect sizes for intervention efficacy ( Table 4) . As with community-based programs, all interventions were related to HIV prevention or testing; there were no interventions related to HIV care engagement for women living with HIV.
Five programs in Table 3 enrolled only women or incorporated women-specific, trauma-informed content. The HOME (Health Options Mean Empowerment) intervention, for example, was a peer-educator based educational program about HIV risk reduction [43] . Women were recruited from a prison visitor center, trained to be peer-educators, and invited to group sessions timed with their prison visits. The program also partnered extensively with CBOs to provide health fairs in the prison visitors' parking lot on a weekend visiting day. While there was a significant intervention effect on HIV testing compared to an unexposed cohort, the convenience sample was heterogeneous and included sisters, mothers, and friends in addition to sexual partners of male inmates. HOME was subsequently adapted for community-based delivery (Project HAPPEN; Health Access Program for Prevention, Empowerment and Networking for Women [48] ). HAP-PEN was feasible and acceptable in part because of its flexibility and patient-centered focus but again was limited by accrual, attrition, and heterogeneity of the study sample. Another major gender-specific intervention referred HIV uninfected women from multiple CJ sites (jail, parole, probation) and enrolled those eligible in partnership with a county HIV prevention program [50] . The HIV and IPV risk reduction intervention was based on motivational interviewing techniques and found to successfully and sustainably reduce condomless sex, needle sharing, and IPV compared to controls. A major drawback to this study was its time-intensiveness, which could limit replicability in other settings.
Discussion
We performed a scoping review of the published literature to evaluate CJ settings as points of access to women for HIV prevention and treatment interventions. The 42 unique Visitors [43] -Low population turnover [38] -Highly structured setting -Highly controlled setting [100] -Able to maintain continuity of contact between research team and participants [67, 88] -Can create buy-in from prison staff (staff to help recruit participants) [38, 39, [65] [66] [67] -Integrated medical care-point of contact for certain conditions (e.g. HIV, Hepatitis C) [35, 90] -Intervention may be redundant with mandated programming -Heterogeneous population [102] studies that met inclusion criteria for synthesis represented a broad range of intervention types and sampling techniques. Instead of using the CJ ''system'' as a massive umbrella term, we sought to disaggregate the various components within it, comparing the strengths and challenges of each from an implementation science perspective (Table 4) . In doing so, we uncovered the strengths and weaknesses of each type of CJ setting (jail, prison, probation, parole, courts, etc.) in terms of being an access point for intervention. For example, an HIV testing intervention that involves large populations with high turnover might best be implemented in a jail; a resource-intensive educational program might best be operationalized in a prison; or a broad outreach program might benefit from the flexibility and centrality of a probation office. Capacitybuilding within different CJ sectors is key to optimizing health outcomes for people who are CJ-involved [51] . The most successful interventions overall were those in which research staff had established rapport within the CJ site, either because they were more informed about the needs of the target population or because they were able to best align the program focus with the priorities of the CJ site. For example, an HIV psychoeducational program for probation/parole officers and onsite HIV testing was facilitated because one of the researchers was also a probation officer [52] . It is often perceived as a conflict when researchers serve dual roles of researchers and interventionists, in which case close partnerships between academic and correctional centers can be highly effective [53] . -Potentially less perceived coercion because not affiliated with CJ system (strengthens rapport with clients) [99] -Peer programs may alleviate stigma, isolation [97] -Low cost, promotes sustainability [97] -May embed intervention into existing activities [48] -Can expand harm reduction techniques that might be prohibited in CJS [99] -Requires extensive collaboration -Program dropouts = study droupouts [48] ; sustainability? [50] -Heterogeneous population [98] -High rates of attrition in some studies [98] AIDS Behav (2017) 21:3527-3548 3543 Women comprise 25% of PLH in the U.S. [54, 55] . Countless more women are at high risk of acquiring HIV because of transactional sex, injection and non-injection drug use, underlying psychiatric disorders, interpersonal violence exposure, and overlapping sex and drug use networks [56] . Yet women who could most benefit from evidence-based HIV prevention and treatment interventions are frequently isolated from systems of care and support [57] . In the absence of women-specific HIV behavioral or biomedical prevention strategies, women face multilevel barriers to care engagement and continue to experience disparate health outcomes with attendant morbidity and mortality, acquire HIV, and may transmit HIV to sex and drug use partners. Evidence-based effective HIV prevention and treatment interventions are thus critical to women's health but hinge on being able to effectively reach high-risk women.
Women, who are a minority in the intertwined epidemics of HIV and incarceration, were still relatively under-represented in the CJ interventions synthesized here. Even fewer interventions incorporated women-specific and/or trauma-informed content, but those that did achieved more compelling intervention effects on HIVrelated outcomes. This finding reflects known gender differences in the medical, psychiatric, and social service needs [10, 58] , longitudinal HIV treatment outcomes during and following incarceration [59, 60] , and HIV risk behaviors [13, 56] of CJ-involved populations. To be gender-specific (and thereby culturally competent) for target audiences of CJ-involved women, interventions should incorporate HIV risk reduction strategies that center on achieving self-efficacy or empowerment and acknowledge relational factors like IPV that contribute to women's HIV risk and care engagement. At a minimum, larger studies of HIV interventions for CJ populations can evaluate gender as a mediating and moderating factor that significantly influences outcomes.
Women who are CJ-involved often experience extraordinary stigma related to their incarceration, substance use, commercial sex work, and other risk behaviors [13] . Stigma can exacerbate health disparities to negatively affect health outcomes and also restrict access, limiting the potential for intervention delivery [61] . Because women comprise a minority of CJ-involved persons, they are often absent from interventions despite their markedly elevated HIV risk. This represents important areas for future research as HIV prevention efforts expand globally, especially since women who use drugs or engage in commercial sex work, like many CJ-involved, are identified by the World Health Organization as a key target population for intervention [62] .
From an implementation science perspective [63] , ''access points'' for HIV prevention and care and related intervention delivery have in common several key factors: (1) a population who stands to benefit from the intervention routinely interacts with the site/system; (2) the site can sustainably support research staff (e.g., in terms of cost, space, technology); (3) the priorities of the site's organization align with the missions of the intervention; and (4) there are few structural barriers to entry (e.g., in terms of location, hours of operation, cost). Examples of access points for health interventions include emergency departments, clinical care sites, community-based organizations, addiction treatment programs, and others. Women involved in CJ systems may face serious challenges when they access care in these healthcare settings if they do not address women's specific needs or lifestyles, counter stigma (e.g., stigma associated with HIV, substance use, or CJ involvement), or are not supported by public policies that enable access.
While this scoping review was intended to be exhaustive, it is not without limitations. CJ settings may have other HIV prevention and treatment programs in place for women that have not been rigorously tested or described in the published literature, though we sought to describe only evidence-based interventions. We focused our search on the U.S. CJ system, the organization and conduct of which is distinct from other settings globally. Inclusion was also limited to studies that accessed sample populations through CJ settings as ports of entry, thereby missing interventions for CJ populations in other settings. Notwithstanding these limitations, this is the first systematic review to examine CJ settings as points of access to women for HIV interventions.
Synthesis and Future Directions for Research
Several major themes emerged from this scoping review: (1) CJ-based HIV interventions are most effective when research is aligned with the priorities of the CJ system, stakeholders are involved, and research methods are adapted to suit the structure of the CJ setting; (2) Women are underrepresented and under-evaluated in CJ-based HIV interventional research; and (3) Successful CJ-based HIV interventions for women incorporate women-specific content, including building self-efficacy. Most HIV interventions addressed prevention and focused on psychoeducational or behavioral approaches. Missing from the literature is any description of biomedical interventions for HIV prevention, including HIV pre-exposure prophylaxis (PrEP) or treatment of sexually transmitted infections (STIs), which is clearly needed to push the field forward and align with scientific developments. Although most studies focused on HIV risk behaviors as outcomes, risk behaviors were inconsistently defined-a deficiency that could be addressed through measure harmonization [64] . Despite a wealth of new point-of-care and rapid testing technologies, there is also limited data on HIV testing for CJ-involved women. We could not identify any studies that addressed the HIV care continuum for women living with HIV and interfacing with community-based or other CJ supervision sites, perhaps because it is more difficult to measure the HIV care continuum in community settings where care is more widely dispersed. Future work is needed to address the specific health needs of women who interact with the multiple diverse components of CJ systems, with attention to SUDs, CSW, IPV exposure, and psychiatric disorders that often affect women's healthcare engagement. While we intended to inform implementation science and subsequent development of women-specific HIV interventions, most included studies focused on intervention efficacy rather than real-world effectiveness. The literature has not sufficiently addressed implementation factors that may help or impede the use and dissemination of HIV evidence-based intervention in CJ real-world settings. More research needs to be conducted and funded in this area.
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